Soon after her first round of chemotherapy in March 2020, Brighid Willis, her family and care team had to pivot quickly due to the COVID-19 pandemic.

Thomas Alexander, MD, MPH, and colleagues published findings from a study that found pairing venetoclax with low-dose navitoclax and chemotherapy had promising efficacy in patients with difficult to treat leukemia and lymphoma.

A second cancer diagnosis took an emotional toll on Janet Geisler. After treatment, she has found peace and support through meditation and exercise, and offers encouragement to other patients who may be experiencing the same darkness.

Daniel Reuland, MD, MPH, believes that a physician should ask about a patient’s informed values and preferences regarding key tradeoffs of lung cancer screening and use that information to reach a decision that makes sense for the patient.

The editorial, published in JAMA, comes after the U.S. Preventive Services Task Force’s newly released recommendation to expand eligibility for annual lung cancer screening with low-dose computed tomography.

A comprehensive review of articles on lung cancer prevention screening with low-dose spiral computed tomography shows there are both benefits and harms from screening.

As part of a study led by Matthew Foster, MD, the advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia.

The study by Marc Emerson, PhD, MPH, et al. is believed to be the first to look at the hormone therapy regimens of American Indian and Alaska Native women with breast cancer.

Adam O. Goldstein, MD, MPH, and Leah M. Ranney, PhD, have published a study that found that smokers who saw messages about tobacco chemicals with associated health risks expressed greater desire to quit smoking.

The $175,000 two-year grant will fund Shetal Patel, MD, PhD, in her research of the role of myeloid cells in lung cancer treatment response.